Synthesis method | Sources of EV | Hydrogel material | Detail method | Result | References |
---|---|---|---|---|---|
Combining EVs after crosslink | PRP | Chitosan/silk hydrogel | EVs absorbed by cross-linked hydrogels | Promote diabetic wound healing, enhance collagen deposition and accelerate angiogenesis | [59] |
GMSC | Chitosan/silk hydrogel | EVs absorbed by cross-linked hydrogels | Promote diabetic wound healing, enhance collagen deposition, accelerate angiogenesis and nerve regeneration | [54] | |
Periosteum cells | NAGA/GelMA/Laponite/glycerol hydrogel | EVs absorbed by cross-linked hydrogels | Promote FB and HUVEC viability, proliferation, migration, tube formation and the expression of FGF-1; promote diabetic wound healing, enhance collagen deposition, accelerate angiogenesis | [112] | |
Crosslink by agents after combining EVs | HUVEC | GelMA | The mixture of GelMA, photoinitiator 2959 and HUVEC-EVs crosslinked under UV light | Promote FB and HaCaT viability, proliferation and migration; promote wound healing, enhance collagen deposition, accelerate angiogenesis | [50] |
ADSC | alginate hydrogel | The mixture of alginate and ADSC-EVs crosslinked by adding calcium chloride (CaCL2) solution | Promote HUVEC viability, proliferation and migration; promote wound healing, enhance collagen deposition, accelerate angiogenesis | [66] | |
ESC | GelMA | The mixture of GelMA, LAP photoinitiator and ESC-EVs crosslinked under UV light | Promote HUVEC viability, proliferation, migration and tube formation; promote diabetic wound healing, enhance collagen deposition, accelerate angiogenesis | [55] | |
Crosslink without agents after combining EVs | human endometrial stem cell (hEnSCs) | chitosan/glycerol hydrogel | The stable hydrogel construct was obtained through electrostatic interaction between positive NH2Â charges of Ch and negative OH charge of glycerol as well as hydrogen-bonding interactions between the Ch chains. | Promote FB viability, proliferation and migration; promote wound healing, enhance collagen deposition, accelerate angiogenesis | [113] |
Synovium-derived stem cells | Chitosan hydrogel | The hydrogel mixture with SMSC-EVs was placed at -20 °C for 2 h, and then NaOH solution was added and the mixture was kept at 4 °C for 4 h | Promote FB and HMEC-1 viability, proliferation, migration and tube formation; promote diabetic wound healing, enhance collagen deposition, accelerate angiogenesis | [57] | |
royal jelly | Type I collagen hydrogel | The hydrogel was mixed with royal jelly derived EVs at 4 °C and polymerized at 37 °C | Promote FB viability, proliferation and migration; form antibacterial biomembrane | [60] | |
Crosslink in situ through shear thinning | ADSC | FHE hydrogel (F127/OHA-EPL) | The hydrogel was injected into wounds after the solid-liquid transition under injection pressure and quickly gelated in situ | Promote HUVEC viability, proliferation, migration and tube formation; promote diabetic wound healing, enhance collagen deposition, accelerate angiogenesis | [37] |
ADSC | FEP scaffold (F127-PEI/APu) | The hydrogel was injected into wounds after the solid-liquid transition under injection pressure and quickly gelated in situ | Promote HUVEC viability, proliferation, migration and tube formation; promote diabetic wound healing, enhance collagen deposition, accelerate angiogenesis and cell proliferation in wounds | [114] | |
PMSCs | methylcellulose-chitosan hydrogel | The hydrogel was injected into wounds after the solid-liquid transition under injection pressure and quickly gelated in situ | Promote diabetic wound healing, enhance collagen deposition, accelerate angiogenesis and regulate the expression of Bcl-2, Bax and VEGF | [115] | |
Crosslink in situ through temperature control | hUCMSC | PF-127 hydrogel | The hydrogel mixture stored at 4 °C and the gel transition happened at 37 ℃ on wounds | Promote HUVEC viability, proliferation and migration; promote diabetic wound healing, enhance collagen deposition, accelerate angiogenesis and cell proliferation in wounds, and regulate the expression of VEGF and tgf-β | [73] |
ADSC | PF-127 hydrogel | The hydrogel mixture stored at 4 °C and the gel transition happened at 37 ℃ on wounds | Promote wound healing, enhance collagen deposition, accelerate angiogenesis and cell proliferation in wounds, and regulate wound inflammation | [116] | |
M2 macrophage | HAh and Haaq hydrogel | Both hydrogel precursors were injected in situ on the wounds and the gel transition happened by an efficient Schiff base reaction between the hydrazide moieties of HAh and the aldehyde moieties of HAaq | Promote FB and HUVEC viability, proliferation and tube formation; promote diabetic wound healing, enhance collagen deposition, accelerate angiogenesis and reduce wound ROS level | [45] | |
3D bioprinting | THP-1-derived activated macrophages (MΦ) | LVG-RGD/gelatin hydrogel | 3D bioprinting was performed using the freeform reversible embedding of suspended hydrogel (FRESH) approach | Promoted NRCM viability, metabolic activity, and reduced their apoptosis | [117] |
Lyosecretome | SA-SF hydrogel | Printability and shape fidelity of the SA-SF hydrogel were assessed using CELLINK INKREDIBLE+, an extrusion-based 3D bioprinter | Realize controllable EV-release kinetics with better EV-controlled-release effect | [118] | |
Lyosecretome | PCL/alginate hydrogel | PCL scaffolds were 3D-printed with the Cellink INKREDIBLE+, a pneumatic extrusion-based 3D bioprinter | Realize controllable EV-release kinetics with better EV-controlled-release effect | [72] |